SCHEMBL202014

SCHEMBL202014

COC(=O)c1ccccc1CCC(O)c1cccc(C=Cc2ccc3ccc(Cl)cc3n2)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8761819 1.00 — —
SCHEMBL457832 1.00 — —
SCHEMBL202015 1.00 — —
SCHEMBL202013 1.00 — —
SCHEMBL202012 1.00 — —
Water SCHEMBL1133112 0.99 — —
Water SCHEMBL2564078 0.99 — —
Water SCHEMBL7951968 0.99 — —
Water SCHEMBL1133115 0.99 — —
SCHEMBL13992171 0.92 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8617853-B2 Ketoreductase polypeptides for the production of (S,E)-methyl 2-(3-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-hydroxypropyl)benzoate CODEXIS, INC. (US) 2013-12-31 — — US claimed
US-20120184000-A1 KETOREDUCTASE POLYPEPTIDES FOR THE PRODUCTION OF (S,E)-METHYL 2-(3-(3-(2-(7-CHLOROQUINOLIN-2-YL)VINYL)PHENYL)-3-HYDROXYPROPYL)BENZOATE CODEXIS, INC. (US) 2012-07-19 — — US claimed
EP-2203557-B1 KETOREDUCTASE POLYPEPTIDES AND USES THEREOF CODEXIS INC (US) 2012-02-29 — — EP claimed
US-8088610-B2 Ketoreductases for the production of (S,E)-methyl 2-(3-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-hroxypropyl)benzoate CODEXIS, INC. (US) 2012-01-03 — — US claimed
CN-101889081-A Ketoreductase polypeptides and uses thereof CODEXIS INC 2010-11-17 — — CN claimed
EP-2203557-A1 KETOREDUCTASE POLYPEPTIDES AND USES THEREOF Codexis, Inc. (US) 2010-07-07 — — EP claimed
US-20090155863-A1 KETOREDUCTASE POLYPEPTIDES AND USES THEREOF CODEXIS, INC. (US) 2009-06-18 — — US claimed
WO-2009042984-A1 KETOREDUCTASE POLYPEPTIDES AND USES THEREOF CODEXIS, INC. (US) 2009-04-02 — — WO claimed
CN-118421578-A Construction and application of improved carbonyl reductase and engineering bacteria thereof 山东新时代药业有限公司 2024-08-02 — — CN disclosed
CN-117050958-A Ketoreductase polypeptides and uses thereof 宿迁阿尔法科技有限公司 2023-11-14 — — CN disclosed
CN-117024340-A Synthesis method of montelukast sodium 迪嘉药业集团股份有限公司 2023-11-10 — — CN disclosed
CN-111474260-A Detection method of montelukast sodium intermediate 中山奕安泰医药科技有限公司 2020-07-31 — — CN disclosed
US-10093905-B2 Ketoreductases C-LECTA GMBH (DE) 2018-10-09 — — US disclosed
EP-3134519-B1 KETOREDUCTASES C LECTA GMBH (DE) 2018-06-06 — — EP disclosed
WO-2008032099-A2 PROCESS FOR THE PREPARATION OF MONTELUKAST, AND INTERMEDIATES THEREFOR CIPLA LIMITED (IN) 2008-03-20 — — WO disclosed
EP-1783117-A1 Process for the preparation of a leukotriene antagonist and intermediates thereof ESTEVE QUIMICA, S.A. (ES) 2007-05-09 — — EP disclosed
EP-0399818-B1 Diarylstyrylquinoline diacids MERCK FROSST CANADA INC (CA) 1995-08-16 — — EP disclosed
US-5204358-A Antiallergens; antiinflammatory agents; treatment of asthma, rhinitis, bronchitis and skin diseases MERCK FROSST CANADA, INC. (CA) 1993-04-20 — — US disclosed
US-5104882-A Leukotriene antagonists MERCK FROSST CANADA, INC. (CA) 1992-04-14 — — US disclosed
EP-0399818-A1 Diarylstyrylquinoline diacids MERCK FROSST CANADA INC. (CA) 1990-11-28 — — EP disclosed
Send feedback